Sermorelin & GHRP-6 & GHRP-2 Blend (9mg) – Triple-Action Synergistic GH Research Peptide

Welcome to Liaocheng Yixin Company, your trusted source for premium sermorelin ghrp-6 ghrp-2 9mg blend for research. As a specialized peptide synthesis manufacturer operating from our facility in Shandong Province, China, we provide high-quality research compounds for the global scientific community.

This 9mg triple blend combines Sermorelin (the shortest synthetic GHRH analog with full biological activity) with two mechanistically distinct growth hormone-releasing peptides—GHRP-6 and GHRP-2. This tripartite formulation represents one of the most comprehensively documented combinations for stimulating endogenous GH secretion, with published human data demonstrating significant IGF-1 elevation . Our sermorelin ghrp-6 ghrp-2 9mg blend for research offers investigators a convenient, precisely formulated tool for endocrine signaling, body composition, and metabolic research.sermorelin ghrp-6 ghrp-2 9mg blend for research

What is the Sermorelin & GHRP-6 & GHRP-2 Blend?

This 9mg lyophilized blend contains three research peptides that work through complementary pathways at the hypothalamic-pituitary axis:

Sermorelin is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal segment of the naturally occurring 44-amino-acid GHRH . GHRP-6 is a synthetic hexapeptide that activates the ghrelin receptor with prominent appetite-stimulating effects . GHRP-2 (Pralmorelin) is the most potent synthetic GHRP, with 2-3 times the GH-releasing activity of GHRP-6 per unit dose .

Mechanism of Action in Research

The blend combines three distinct pathways to produce synergistic GH release through non-redundant mechanisms on the same somatotroph cell :

GHRH Receptor Pathway (Sermorelin)

Sermorelin binds the GHRH receptor (GHRHR), a class B GPCR on pituitary somatotrophs, activating the Gs/adenylyl cyclase/cAMP/PKA cascade. PKA phosphorylates L-type calcium channels and CREB transcription factor, simultaneously triggering acute GH release and stimulating GH gene transcription. This is the “stockpile preparation” pathway—it increases intracellular GH stores in vesicles .sermorelin ghrp-6 ghrp-2 9mg blend for research

Ghrelin Receptor Pathway (GHRP-6 & GHRP-2)

Both GHRP-6 and GHRP-2 activate GHS-R1a, a Gq-coupled receptor. This triggers phospholipase C, generating IP3 and DAG, mobilizing intracellular calcium stores, and activating protein kinase C (PKC). The resulting calcium surge triggers immediate exocytosis of pre-formed GH vesicles. This is the “unloading of stores” pathway .

Synergistic Amplification

The combination exploits dual signaling convergence on somatotroph calcium levels: Sermorelin-mediated cAMP/PKA signaling sensitizes voltage-gated calcium channels, while GHRP-mediated IP3/PKC signaling mobilizes intracellular calcium . The combined calcium signal produces GH exocytosis 3-5 fold greater than additive predictions . Additionally, GHRP-mediated somatostatin suppression extends the window during which GHRH can act, further amplifying GH pulse amplitude and duration. sermorelin ghrp-6 ghrp-2 9mg blend for research

Preserved Physiologic Pulsatility

Unlike exogenous GH administration (which suppresses endogenous production and causes continuous exposure), GH secretagogues stimulate endogenous release and preserve the hypothalamic-pituitary feedback loop . The physiologic pulsatile pattern preferentially activates the growth-promoting STAT5b signaling pathway and avoids GH resistance that occurs with constant receptor stimulation .

Scientific Research Applications

Growth Hormone Axis and Synergy Studies

Published human research has demonstrated that the combination of Sermorelin, GHRP-6, and GHRP-2 significantly elevates IGF-1 levels. In a retrospective study of 14 hypogonadal men, treatment with 100 mcg of each peptide three times daily for an average of 134 days increased mean IGF-1 from 159.5 ng/mL to 239.0 ng/mL (p < .0001) . The combination’s synergistic effect arises from different molecular effects on pathways, with the compounds interacting at different receptors to stimulate different methods of releasing growth hormone .

Body Composition and Metabolic Research

GHRP/SERM therapy has been studied for its potential to increase lean body mass and reduce fat mass in men with wasting conditions . Research suggests the combination may be beneficial in conditions where increases in fat-free mass are desirable . As GH secretagogues stimulate GH release and “restore the growth hormone to what it should be” , they offer a research paradigm distinct from exogenous GH administration.

Appetite and Recovery Research

GHRP-6’s pronounced appetite-stimulating effect (activation of hypothalamic NPY/AgRP neurons) makes it valuable for studying orexigenic signaling pathways. The ability of GHRP-2 to stimulate appetite has been noted in research, with calls for further studies to evaluate potential use in malnutrition models .

Endocrinology and Receptor Pharmacology

Sermorelin preserves physiologic GH pulsatility and feedback regulation, unlike exogenous GH, which suppresses endogenous production . The blend’s preserved pulsatile pattern avoids GH resistance that occurs with constant receptor stimulation . Sermorelin has been used in dynamic GH stimulation tests in pediatric endocrinology , and GHRP-2 has demonstrated ability to stimulate GH secretion in a dose-wise manner in growth hormone deficient populations .sermorelin ghrp-6 ghrp-2 9mg blend for research

Important Research Considerations

Evidence Base

Published human data on this combination is limited to small retrospective studies with strict inclusion criteria (n=14) . Response variability is significant, with age, baseline GH status, sleep quality, and genetic factors influencing outcomes.

Dosing and Compliance

The clinical study used a 100 mcg dose of each compound, administered subcutaneously three times daily . Strict compliance to thrice-daily dosing was required to achieve significant IGF-1 elevation .

Anti-Estrogen Interactions

Inhibition of estrogen production or estrogen receptor blockade (e.g., co-administration of aromatase inhibitors or tamoxifen) resulted in smaller increases in IGF-1 levels . Four of the 14 men in the cohort were co-administered an aromatase inhibitor and/or tamoxifen during treatment, and a trend toward significantly lower IGF-1 levels in men on antiestrogen therapy was observed .sermorelin ghrp-6 ghrp-2 9mg blend for research

Regulatory Status

Growth hormone-releasing peptides and GHRH analogs are listed under WADA’s Prohibited List in the peptide hormone category. This blend is not FDA-approved and is sold for research use only. A 2021 survey noted the combination is used for conditions including growth hormone deficiency and wasting syndrome .sermorelin ghrp-6 ghrp-2 9mg blend for research

Why Choose Liaocheng Yixin Company?

When sourcing sermorelin ghrp-6 ghrp-2 9mg blend for research, quality and reliability are paramount. Here’s why researchers trust us:

Manufacturer-Direct Quality

We are a legitimate, licensed peptide synthesis company with a physical headquarters in Shandong Province, China. Our facility maintains strict quality control standards.

Verified Purity Standards

Every batch undergoes rigorous testing using HPLC analysis. Our blend meets ≥99% purity standards. Certificates of Analysis are available upon request.

Research-Grade Specifications

• Purity: ≥99% verified by HPLC

• Components: Sermorelin (3mg) + GHRP-6 (3mg) + GHRP-2 (3mg)

• Appearance: White lyophilized powder

• Storage: Store powder at -20°C in a sealed, desiccated container, protected from light and moisture

• Form: Lyophilized powder for research use

• sermorelin ghrp-6 ghrp-2 9mg blend for research

Quality Assurance & Testing

Every batch undergoes comprehensive quality control:

1. Synthesis by experienced chemists using solid-phase peptide synthesis

2. Purification via preparative HPLC

3. Analysis using HPLC for purity verification

4. Mass Spectrometry for molecular weight confirmation

5. Packaged in sterile conditions for research use

6. sermorelin ghrp-6 ghrp-2 9mg blend for research

: How does the Sermorelin, GHRP-6 & GHRP-2 blend work in research?

A: Sermorelin activates the GHRH receptor (cAMP/PKA pathway), priming the intracellular GH pool, while GHRP-6 and GHRP-2 both activate the ghrelin receptor (Gq/calcium pathway), triggering GH vesicle exocytosis. This dual convergence on somatotroph calcium levels produces synergistic GH release 3-5 fold greater than additive predictions .

: What distinguishes GHRP-6 from GHRP-2 in this blend?

A: GHRP-6 has a pronounced appetite-stimulating effect and elevates cortisol and prolactin. GHRP-2 is 2-3 times more potent for GH release per unit dose, with less orexigenic effect and more selective GHS-R1a activation .

: What published human data exists for this combination?

A: A retrospective study of 14 hypogonadal men treated with 100 mcg of each peptide three times daily for 134 days demonstrated a significant increase in IGF-1 from 159.5 to 239.0 ng/mL (p < .0001) . The results suggest the combination may be beneficial in wasting conditions .

: What are the key research applications for this blend?

: This blend is used in growth hormone axis synergy studies, body composition and metabolic research, appetite and recovery investigations, and endocrinology research.

: What purity level can I expect?

A: All batches are tested to ensure ≥99% purity by HPLC analysis. Certificates of Analysis are available upon request. sermorelin ghrp-6 ghrp-2 9mg blend for research

: Is this product for human use?

A: No. This blend is manufactured strictly for research use only (RUO). It is not intended for human consumption or clinical applications .

When you need premium sermorelin ghrp-6 ghrp-2 9mg blend for research for your endocrine, metabolic, or receptor pharmacology studies, choose a manufacturer that prioritizes quality, transparency, and reliability. Liaocheng Yixin Company combines expert peptide synthesis capabilities with rigorous quality control to deliver research materials you can trust. sermorelin ghrp-6 ghrp-2 9mg blend for research